brassinosteroids (BR) signaling pathway is regulated by a complex regulatory mechanism, and BRI1 is negatively regulated by BZR1 and BES1 at the transcriptional level. BZR1 mediates downstream brassinolide regulated growth response and feedback inhibition of brassinolide biosynthesis genes.
For research use only, not for clinical use.